Our mission is to improve the lives of patients by developing novel, best-in-class treatments to address some of the most important unmet patient needs. We aim to develop patient-focused solutions by applying our innovative science and technologies with well-known pharmacology, making our products:
- More effective than other pharmaceutical agents in the same class
- Safer or better tolerated than other pharmaceutical agents in the same class
- Better able to address the multiple pathways of a disease or disorder through new mechanisms of action and delivery
- Potentially able to reduce the dependence on other classes of drugs with more harmful side effects, such as opioids
Also, by applying our technologies to already-approved pharmacological agents and utilizing the 505(b)(2) regulatory pathway in the United States, we seek to potentially accelerate the development and lower the clinical and regulatory risk of our product candidates.